UY26119A1 - Nuevo producto farmacéutico - Google Patents
Nuevo producto farmacéuticoInfo
- Publication number
- UY26119A1 UY26119A1 UY26119A UY26119A UY26119A1 UY 26119 A1 UY26119 A1 UY 26119A1 UY 26119 A UY26119 A UY 26119A UY 26119 A UY26119 A UY 26119A UY 26119 A1 UY26119 A1 UY 26119A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compound
- containing peaks
- spectrum
- pharmaceutical product
- new pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Una forma polimórfica de la sal del ácido maleico de la 5-(4-(2(N-metil-N(2-piirdil amino)etoxil bencil tiazolidin-2,4-diona (el polimorfo), que se caracteriza porque proporciona: (i) un espectro del infrarrojo que contiene picos a 1752,1546,1154,621 y 602 c; y7o (ii) un espectro de Raman que contiene picos a 1751, 1243 y 602 cm; y/o (iii) un espectro de resonancia magnética nuclear de estado sólido que contiene picos a 111,9, 114,8, 119,6, 129,2, 134,0, 138,0, 144,7, 153,2, 157,1, 170,7, 172,0 y 175,0 ppm; y/o (iv) una distribución de difracción de polvo de rayos X (XRPD) que produce unos espacios reticulares calculados de 6,46,5,39,4,83,4,68,3,71,3,63,3,58 y 3,48 Angstroms; un proceso para preparar este compuesto, una composición farmacéutica que contiene dicho compuesto, y el uso de dicho compuesto en medicina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9909471.6A GB9909471D0 (en) | 1999-04-23 | 1999-04-23 | Novel compounds |
| GBGB9912195.6A GB9912195D0 (en) | 1999-05-25 | 1999-05-25 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26119A1 true UY26119A1 (es) | 2000-12-29 |
Family
ID=26315459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26119A UY26119A1 (es) | 1999-04-23 | 2000-04-24 | Nuevo producto farmacéutico |
Country Status (36)
| Country | Link |
|---|---|
| EP (2) | EP1175418A2 (es) |
| JP (1) | JP2002543076A (es) |
| KR (1) | KR100744361B1 (es) |
| CN (1) | CN1152878C (es) |
| AP (1) | AP1607A (es) |
| AR (2) | AR023750A1 (es) |
| AU (2) | AU4307200A (es) |
| BG (1) | BG65517B1 (es) |
| BR (1) | BR0009935A (es) |
| CA (1) | CA2370262A1 (es) |
| CO (1) | CO5170419A1 (es) |
| CZ (1) | CZ20013801A3 (es) |
| DZ (1) | DZ3164A1 (es) |
| EA (1) | EA003031B1 (es) |
| EG (1) | EG23937A (es) |
| GC (1) | GC0000250A (es) |
| HK (1) | HK1045152A1 (es) |
| HR (1) | HRP20010774A2 (es) |
| HU (1) | HUP0200937A3 (es) |
| IL (1) | IL146115A0 (es) |
| MA (1) | MA26786A1 (es) |
| MX (1) | MXPA01010822A (es) |
| MY (1) | MY138673A (es) |
| NO (1) | NO320587B1 (es) |
| NZ (1) | NZ515167A (es) |
| OA (1) | OA11873A (es) |
| PE (1) | PE20010045A1 (es) |
| PL (1) | PL351685A1 (es) |
| SK (1) | SK14932001A3 (es) |
| TR (1) | TR200103060T2 (es) |
| TW (1) | TWI288749B (es) |
| UA (1) | UA67845C2 (es) |
| UY (1) | UY26119A1 (es) |
| WO (1) | WO2000064893A2 (es) |
| YU (1) | YU75401A (es) |
| ZA (1) | ZA200108718B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| IL145796A0 (en) * | 1999-04-13 | 2002-07-25 | Us Health | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| OA11871A (en) | 1999-04-23 | 2006-03-27 | Smithkline Beecham Plc | Novel pharmaceutical. |
| ES2203453T3 (es) | 1999-04-23 | 2004-04-16 | Smithkline Beecham Plc | Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona. |
| GB0006133D0 (en) | 2000-03-14 | 2000-05-03 | Smithkline Beecham Plc | Novel pharmaceutical |
| US7241895B2 (en) * | 2000-09-26 | 2007-07-10 | Dr. Reddy's Laboratories Limited | Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| WO2004062667A1 (en) * | 2003-01-08 | 2004-07-29 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
| GB0307259D0 (en) * | 2003-03-28 | 2003-05-07 | Glaxo Group Ltd | Process |
| EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| TW201336497A (zh) * | 2007-02-08 | 2013-09-16 | Daiichi Sankyo Co Ltd | 噻唑啶二酮化合物之結晶型及其製法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9726566D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726563D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
-
2000
- 2000-04-19 PE PE2000000363A patent/PE20010045A1/es not_active Application Discontinuation
- 2000-04-19 SK SK1493-2001A patent/SK14932001A3/sk unknown
- 2000-04-19 KR KR1020017013592A patent/KR100744361B1/ko not_active IP Right Cessation
- 2000-04-19 OA OA1200100277A patent/OA11873A/en unknown
- 2000-04-19 BR BR0009935-0A patent/BR0009935A/pt not_active Application Discontinuation
- 2000-04-19 JP JP2000614245A patent/JP2002543076A/ja active Pending
- 2000-04-19 EA EA200101122A patent/EA003031B1/ru not_active IP Right Cessation
- 2000-04-19 MX MXPA01010822A patent/MXPA01010822A/es active IP Right Grant
- 2000-04-19 TR TR2001/03060T patent/TR200103060T2/xx unknown
- 2000-04-19 CA CA002370262A patent/CA2370262A1/en not_active Abandoned
- 2000-04-19 EP EP00922793A patent/EP1175418A2/en not_active Withdrawn
- 2000-04-19 AU AU43072/00A patent/AU4307200A/en not_active Abandoned
- 2000-04-19 CN CNB008090548A patent/CN1152878C/zh not_active Expired - Fee Related
- 2000-04-19 CO CO00028927A patent/CO5170419A1/es not_active Application Discontinuation
- 2000-04-19 DZ DZ003164A patent/DZ3164A1/xx active
- 2000-04-19 HU HU0200937A patent/HUP0200937A3/hu unknown
- 2000-04-19 AP APAP/P/2001/002329A patent/AP1607A/en active
- 2000-04-19 AR ARP000101866A patent/AR023750A1/es unknown
- 2000-04-19 IL IL14611500A patent/IL146115A0/xx unknown
- 2000-04-19 YU YU75401A patent/YU75401A/sh unknown
- 2000-04-19 CZ CZ20013801A patent/CZ20013801A3/cs unknown
- 2000-04-19 UA UA2001117940A patent/UA67845C2/uk unknown
- 2000-04-19 NZ NZ515167A patent/NZ515167A/xx unknown
- 2000-04-19 EP EP02080319A patent/EP1277753A1/en not_active Withdrawn
- 2000-04-19 AR ARP000101861A patent/AR023560A1/es unknown
- 2000-04-19 PL PL00351685A patent/PL351685A1/xx not_active Application Discontinuation
- 2000-04-19 WO PCT/GB2000/001522 patent/WO2000064893A2/en not_active Application Discontinuation
- 2000-04-21 MY MYPI20001706A patent/MY138673A/en unknown
- 2000-04-22 EG EG20000511A patent/EG23937A/xx active
- 2000-04-23 GC GCP2000625 patent/GC0000250A/en active
- 2000-04-24 TW TW089107636A patent/TWI288749B/zh not_active IP Right Cessation
- 2000-04-24 UY UY26119A patent/UY26119A1/es not_active Application Discontinuation
-
2001
- 2001-10-22 NO NO20015148A patent/NO320587B1/no unknown
- 2001-10-22 MA MA26379A patent/MA26786A1/fr unknown
- 2001-10-22 HR HR20010774A patent/HRP20010774A2/hr not_active Application Discontinuation
- 2001-10-23 ZA ZA200108718A patent/ZA200108718B/xx unknown
- 2001-11-20 BG BG106122A patent/BG65517B1/bg unknown
-
2002
- 2002-03-20 AU AU27551/02A patent/AU771342B2/en not_active Ceased
- 2002-06-28 HK HK02104877.8A patent/HK1045152A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26121A1 (es) | Nuevo compuesto farmacéutico | |
| UY26119A1 (es) | Nuevo producto farmacéutico | |
| EA200101119A1 (ru) | Новый фармацевтический препарат | |
| EA200000656A1 (ru) | Замещенное производное тиазолидиндиона, способ его получения и его фармацевтическое применение | |
| UY25308A1 (es) | Procedimiento para la preparación de un hidrato de un derivado de tiazolidin-2,4-diona. | |
| UY25310A1 (es) | Procedimiento para preparar un hidrato de la sal de ácido 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4 diona maleico | |
| ECSP003437A (es) | Nuevos compuestos | |
| ECSP003436A (es) | Nuevos compuestos | |
| ECSP003438A (es) | Nuevos compuestos | |
| ECSP982781A (es) | Hidrato de la sal de maleico de 5-[4- (-n -metil-n- (2-piridil) amino) etoxi) bensil) tiazolidina - 2,4 diona | |
| TH84544A (th) | ไฮเดรทชนิดใหม่ | |
| TH54465A (th) | สารทางเภสัชกรรมชนิดใหม่ | |
| ECSP982779A (es) | Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina | |
| ECSP003434A (es) | Nuevos compuestos | |
| TH54464A (th) | สารทางเภสัชกรรมชนิดใหม่ | |
| TH58462B (th) | สารผสมต่อต้านเบาหวานชนิดใหม่ และการรักษา | |
| ECSP003435A (es) | Nuevos compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20100624 |